FilingSEC EDGAR6-K
Quantum BioPharma Applies for Voluntary Delisting from CSE
· SEC accepted
StageDelisting Application
Filing content
Quantum BioPharma has applied for voluntary delisting from the Canadian Securities Exchange to reduce costs and consolidate trading, while maintaining its Nasdaq listing.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…